BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 20550712)

  • 1. Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus.
    Winzer BM; Paratz JD; Reeves MM; Whiteman DC
    BMC Cancer; 2010 Jun; 10():292. PubMed ID: 20550712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasibility of an exercise intervention in males at risk of oesophageal adenocarcinoma: a randomized controlled trial.
    Winzer BM; Paratz JD; Whitehead JP; Whiteman DC; Reeves MM
    PLoS One; 2015; 10(2):e0117922. PubMed ID: 25706622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.
    Kubo A; Corley DA; Jensen CD; Kaur R
    Nutr Res Rev; 2010 Dec; 23(2):230-46. PubMed ID: 20624335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for Barrett's oesophagus.
    Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett's oesophagus and stage I oesophageal adenocarcinoma.
    di Pietro M; Trudgill NJ; Vasileiou M; Longcroft-Wheaton G; Phillips AW; Gossage J; Kaye PV; Foley KG; Crosby T; Nelson S; Griffiths H; Rahman M; Ritchie G; Crisp A; Deed S; Primrose JN
    Gut; 2024 May; 73(6):897-909. PubMed ID: 38553042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol.
    Nieto T; Tomlinson CL; Dretzke J; Bayliss S; Dilworth M; Beggs AD; Tucker O
    BMJ Open; 2016 Dec; 6(12):e013361. PubMed ID: 27927666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?
    Mayne GC; Bright T; Hussey DJ; Watson DI
    ANZ J Surg; 2012 Sep; 82(9):592-8. PubMed ID: 22901306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's oesophagus: optimal strategies for prevention and treatment.
    Fass R; Sampliner RE
    Drugs; 2003; 63(6):555-64. PubMed ID: 12656653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.
    Wild CP; Hardie LJ
    Nat Rev Cancer; 2003 Sep; 3(9):676-84. PubMed ID: 12951586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus.
    Rubenstein JH; Thrift AP
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):41-50. PubMed ID: 25743455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
    Fitzgerald RC; di Pietro M; O'Donovan M; Maroni R; Muldrew B; Debiram-Beecham I; Gehrung M; Offman J; Tripathi M; Smith SG; Aigret B; Walter FM; Rubin G; ; Sasieni P
    Lancet; 2020 Aug; 396(10247):333-344. PubMed ID: 32738955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's oesophagus: frequency and prediction of dysplasia and cancer.
    Falk GW
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):125-38. PubMed ID: 25743461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and prevention of oesophageal adenocarcinoma.
    Fitzgerald RC
    Recent Results Cancer Res; 2005; 166():35-46. PubMed ID: 15648181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Barrett esophagus. Current situation of the risk and surveillance policy].
    Robaszkiewicz M
    Presse Med; 1994 Dec; 23(40):1846-8. PubMed ID: 7899314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.